Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard J Benjamin

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Blood|May 25, 2023
Cytosolic antigens prime RBC alloantibodiesRichard J Benjamin
Transfusion|June 13, 2012
The REDS-II Donor Iron Status Evaluation (RISE) study: conclusions should not exceed the limitations of the dataRichard J Benjamin
Journal of Clinical Apheresis|May 10, 2005
Bacterial detection in platelet components and the rationale for pathogen inactivation: a blood center perspectiveRichard J Benjamin
Blood|January 14, 2017
Zika virus in the blood supplyRichard J Benjamin
Transfusion|September 6, 2012
The effect of various platelet dosing strategies on transfusion costsRichard J Benjamin
Transfusion|July 1, 2005
The RADAR repository: providing a prospective perspective on the pastRichard J Benjamin
Blood|April 23, 2011
Tracking TRALI in target populationsRichard J Benjamin
Blood|January 30, 2016
Transfusion-related sepsis: a silent epidemicRichard J Benjamin
Blood|April 8, 2021
A conceptual framework for managing iTTPRichard J Benjamin
Transfusion|March 23, 2016
The role of hemovigilance and postmarketing studies when introducing innovation into transfusion medicine practice: the amotosalen-ultraviolet A pathogen reduction treatment modelLaurence Corash, Richard J Benjamin
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Blood|May 25, 2023
Cytosolic antigens prime RBC alloantibodiesRichard J Benjamin
Transfusion|June 13, 2012
The REDS-II Donor Iron Status Evaluation (RISE) study: conclusions should not exceed the limitations of the dataRichard J Benjamin
Journal of Clinical Apheresis|May 10, 2005
Bacterial detection in platelet components and the rationale for pathogen inactivation: a blood center perspectiveRichard J Benjamin
Blood|January 14, 2017
Zika virus in the blood supplyRichard J Benjamin
Transfusion|September 6, 2012
The effect of various platelet dosing strategies on transfusion costsRichard J Benjamin
Transfusion|July 1, 2005
The RADAR repository: providing a prospective perspective on the pastRichard J Benjamin
Blood|April 23, 2011
Tracking TRALI in target populationsRichard J Benjamin
Blood|January 30, 2016
Transfusion-related sepsis: a silent epidemicRichard J Benjamin
Blood|April 8, 2021
A conceptual framework for managing iTTPRichard J Benjamin
Transfusion|March 23, 2016
The role of hemovigilance and postmarketing studies when introducing innovation into transfusion medicine practice: the amotosalen-ultraviolet A pathogen reduction treatment modelLaurence Corash, Richard J Benjamin
Pageof 9